Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma

Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma

The Oncology Gold Standard (OGS) Expert Group on renal cell carcinoma (RCC) developed the consensus statement to provide community oncologists practical guidelines on the management of advanced clear cell (cc) RCC using published evidence, practical experience of experts in real life management, and...

Full description

Bibliographic Details
Main Authors:	U Batra, P M Parikh, K Prabhash, H B Tongaonkar, P Chibber, D Dabkara, C Deshmukh, N Ghadyalpatil, S Hingmire, A Joshi, S K Raghunath, S Rajappa, R Rajendranath, S K Rawal, Manisha Singh, R Singh, S P Somashekhar, R Sood
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2016-01-01
Series:	South Asian Journal of Cancer
Subjects:	Guidelines immuno-oncology kidney cancer mammalian target of rapamycin inhibitor targeted therapy tyrosine kinase inhibitors vascular endothelial growth factor
Online Access:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2016;volume=5;issue=4;spage=167;epage=175;aulast=Batra

Similar Items

Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series
by: Timothy F. Meiller, et al.
Published: (2015-08-01)

Contemporary Drug-Eluting Stents and Vascular Response
by: Anwer Habib, et al.
Published: (2017-03-01)

Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial
by: Sophie Leducq, et al.
Published: (2019-12-01)

Use of everolimus following kidney transplantation during pregnancy: A case report and systematic review
by: Pony Yee-Chee Chai, et al.
Published: (2023-09-01)

Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Jun Zeng, et al.
Published: (2021-09-01)

mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
by: Joshua Blair, et al.
Published: (2018-06-01)

Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis
by: Stepan M. Esagian, et al.
Published: (2021-02-01)

Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case
by: Soojung Hong, et al.
Published: (2014-05-01)

In vitro Anti-Hantavirus Activity of Protein Kinase Inhibitor 8G1 Targeting AKT/mTOR/eIF4E Signaling Pathway
by: Zhoupeng Li, et al.
Published: (2022-06-01)

Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report
by: Manabu Takai, et al.
Published: (2019-09-01)

Huge soft tissue PEComa with aggressive lung and bone metastases
by: Shih-Hao Tang, et al.
Published: (2017-09-01)

Pulmonary toxicity of mTOR inhibitors in kidney transplantation: A single-center experience
by: Patrícia Valério, et al.
Published: (2021-04-01)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
by: Rita Leal, et al.
Published: (2018-03-01)

Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01)

Acute Hyperglycemia Associated with Anti-Cancer Medication
by: Yul Hwangbo, et al.
Published: (2017-03-01)

Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature
by: Peri M, et al.
Published: (2020-07-01)

Oral Preconditioning of Donors After Brain Death With Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation
by: Sepehr Abbasi Dezfouli, et al.
Published: (2020-06-01)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
by: Yu Mei, et al.
Published: (2017-09-01)

The Effects of Evening Primrose/Hemp Seed Oil Compared to Rapamycin on the Gene Expression of Immunological Parameters in Experimental Autoimmune Encephalomyelitis Splenocytes
by: Soheila Rezapour-Firouzi, et al.
Published: (2020-04-01)

Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design
by: Annabel Maruani, et al.
Published: (2018-06-01)

Nanotechnology-Based Targeting of mTOR Signaling in Cancer
by: Yoon MS
Published: (2020-08-01)

Leucine regulates α-amylase and trypsin synthesis in dairy calf pancreatic tissue in vitro via the mammalian target of rapamycin signalling pathway
by: L. Guo, et al.
Published: (2019-01-01)

Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
by: Ravi K. Paluri, et al.
Published: (2019-11-01)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Belinda Seto
Published: (2012-12-01)

Metastatic renal cell carcinoma: Current scenario and future trends
by: Anubha Bharthuar
Published: (2012-07-01)

Eupafolin ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via PI3K/AKT/mTOR signaling pathway
by: Yan Gao, et al.
Published: (2019-11-01)

Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
by: Jie Yin, et al.
Published: (2018-07-01)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
by: Marlous J. Groenewoud, et al.
Published: (2013-01-01)

Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice[S]
by: Zhenjiang Liu, et al.
Published: (2016-08-01)

Alpha‐lipoic acid inhibits lung cancer growth via mTOR‐mediated autophagy inhibition
by: Peipei Peng, et al.
Published: (2020-04-01)

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
by: Daniel J. Beard, et al.
Published: (2021-09-01)

In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against <i>Leishmania donovani</i> and <i>Trypanosoma brucei</i>
by: Trong-Nhat Phan, et al.
Published: (2020-04-01)

Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care
by: Takashi Hatano, et al.
Published: (2020-10-01)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012-03-01)

Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib
by: Jiaming Xu, et al.
Published: (2020-11-01)

Conversion to mTOR-inhibitors with calcineurin inhibitor elimination or minimization reduces urinary polyomavirus BK load in kidney transplant recipients
by: Chieh-Li Yen, et al.
Published: (2016-07-01)

Advanced Research of mTOR and Lung Carcinoid Tumors
by: Zixuan ZHANG, et al.
Published: (2013-01-01)

Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways
by: Zhengbo Zhao, et al.
Published: (2020-01-01)

Ketamine Rescues Hippocampal Reelin Expression and Synaptic Markers in the Repeated-Corticosterone Chronic Stress Paradigm
by: Jenessa N. Johnston, et al.
Published: (2020-09-01)

Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
by: Pei-Jie Shi, et al.
Published: (2016-02-01)